Forest Laboratories To Acquire Aptalis For $29 Billion In Cash | Latest News RSS feed

Forest Laboratories To Acquire Aptalis For $29 Billion In Cash - Latest News


Forest Labs (FRX) to Acquire Privately-Held Aptalis in $2.9B Deal

Forest Laboratories, Inc. (NYSE: FRX) announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal (GI) and Cystic Fibrosis comp... read more

Aptalis to be Acquired by Forest Laboratories for $2.9 Billion

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Aptalis, a privately-held leading specialty pharmaceutical company, today announced that it has signed a definitive agreement to be acquired by Forest Laboratories ... read more

Forest Laboratories - Aptalis Deal Sparks More Enthusiasm

Acquisition Of Aptalis Forest Laboratories announced that it will acquire Aptalis for $2.9 billion in cash. Forest will acquire the privately ... EBITDA of the business rose by 29% to $315 million, va... read more

Looking for another news?


Forest Labs to acquire North Carolina-based Furiex Pharmaceuticals for $1.5 billion

Forest Laboratories ... has entered into a definitive agreement to acquire Furiex Pharmaceuticals, Inc., a drug development collaboration company, for $95 per share, or approximately $1.1 billion in c... read more


Forest Labs To Acquire Furiex Pharma A Deal Potentially Worth $1.46 Billion

... Officer and President of Forest Laboratories, Inc. Furiex is a drug development collaboration company, and Forest has agreed to acquire the company for $95 per share, or approximately $1.1 billion ... read more

Actavis Buys Forest Labs

January 2014 Aptalis ... is acquired for $2.9 billion. February 2014 Actavis proposes $25 billion acquisition. SOURCE: Forest Labs The generic drug maker Actavis will shell out $25 billion in cash and ... read more

Allergan: Trading at a Low Earnings Multiple

In February, Actavis acquired Forest Laboratories for $25 billion. The former spent another $70.5 billiob in November that year to acquire Allergan ... As of Sept. 30, Allergan had $27.39 billion in c... read more

Forest To Acquire Specialty Pharma Firm

Forest Laboratories will shell out $2.9 billion in cash to acquire privately held specialty pharmaceuticals firm Aptalis. The deal for Aptalis, which had sales of $688 million in fiscal 2013, diversif... read more

Corporate Exits Accelerating, Taking Jobs with Them

Bloomberg also reports on GE’s plans to buy Alstom SA of France with $57 billion of cash ... billion to acquire Forest Laboratories Inc. (FRX), setting Forest up for a tax domicile move to Ireland. Be... read more

Forest Laboratories Management Discusses Q3 2014 Results - Earnings Call Transcript

Forest Laboratories (NYSE ... Third, we raised $1.2 billion in an oversubscribed maiden bond offering. Fourth, we named a new, larger management team. Finally, we announced plans to acquire Aptalis fo... read more

Top-Ranked Forest Labs Soars on Buyout News

Shares of Forest Laboratories, Inc. (FRX), a Zacks Rank ... signed a definitive agreement under which Actavis will acquire Forest Labs for a cash and equity transaction valued at about $25 billion or ... read more

Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable

The rating actions follow the firm's announcement that it has entered a definitive agreement to acquire Allergan ... acquisition of Allergan to the close of its $25 billion purchase of Forest Laborato... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us